CYP2C9 genotype does not affect risk of tobacco-related cancer in the general population

Cancer Epidemiology
Diljit Kaur-KnudsenStig E Bojesen

Abstract

CYP2C9 enzymes are important in the metabolism of procarcinogenic chemicals such as polycyclic aromatic hydrocarbons (PAHs) found in tobacco smoke. Two functional variants in the CYP2C9 gene (CYP2C9*2 and CYP2C9*3) are known to be associated with decreased enzyme activity towards tolbutamide and warfarin, while this has not been investigated for PAHs. We hypothesised that these two variants in the CYP2C9 gene influence risk of tobacco-related cancer. In a prospective study of the general population (n=10 392) with 60 years of follow-up, the Copenhagen City Heart Study, we associated two variants of CYP2C9 (CYP2C9*2 and CYP2C9*3) with risk of tobacco-related cancer and all cancer. All results were re-tested in a cross-sectional study of the general population (n=36 856), the Copenhagen General Population Study. We found no association between any of the CYP2C9 genotypes and risk of tobacco-related cancer, individual tobacco-related cancers, or all cancer. For the combined carriers (any CYP2C9*2 or CYP2C9*3 heterozygotes or homozygotes) vs. non-carriers we had 90% statistical power to exclude measures of relative risks below/above 0.8/1.2 and 0.9/1.1 in the Copenhagen City Heart Study and below/above 0.8/1.3 and 0.9/1.1 in the Co...Continue Reading

References

Oct 1, 1996·Pharmacogenetics·M J StubbinsC R Wolf
Oct 27, 2001·British Journal of Clinical Pharmacology·J A Goldstein
Mar 26, 2002·Cancer Letters·Elena García-MartínJosé A G Agúndez
Oct 22, 2002·Lancet·Daniel W Nebert, David W Russell
Sep 21, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Joan FortunyDebra Silverman
Jul 3, 2007·Journal of Agricultural and Food Chemistry·Yan S DingClifford H Watson
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Mar 7, 2008·The New England Journal of Medicine·Ute I SchwarzC Michael Stein
Jun 5, 2008·JAMA : the Journal of the American Medical Association·Ruth Frikke-SchmidtAnne Tybjaerg-Hansen
Oct 31, 2008·The New England Journal of Medicine·Jeppe ZachoBørge G Nordestgaard
Nov 8, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michelle CotterchioPatricia A Harper
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristine H AllinBørge G Nordestgaard
May 9, 2009·Respiratory Medicine·Julie LeeMorten Dahl

❮ Previous
Next ❯

Citations

Oct 17, 2013·Journal of Internal Medicine·S E Bojesen
Aug 11, 2020·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Hannah RMonika K

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.